Novel post-digest isotope coded protein labeling method for phospho- and glycoproteome analysis.

[1]  G. Mazzucchelli,et al.  Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach. , 2010, Talanta.

[2]  Fan Zhang,et al.  Expression profiling of integrins in lung cancer cells. , 2009, Pathology, research and practice.

[3]  Yingming Zhao,et al.  Modification‐specific proteomics: Strategies for characterization of post‐translational modifications using enrichment techniques , 2009, Proteomics.

[4]  Daekyu Sun,et al.  Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein* , 2009, The Journal of Biological Chemistry.

[5]  Hsueh-Kung Lin,et al.  Unique patterns of molecular profiling between human prostate cancer LNCaP and PC‐3 cells , 2009, The Prostate.

[6]  Kazutoshi Fujita,et al.  Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. , 2009, Human pathology.

[7]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[8]  S. Brooks,et al.  Strategies for Analysis of the Glycosylation of Proteins: Current Status and Future Perspectives , 2009, Molecular biotechnology.

[9]  T. Hase,et al.  Integrin Expression Levels Correlate with Invasion, Metastasis and Prognosis of Oral Squamous Cell Carcinoma , 2009, Pathology & Oncology Research.

[10]  U. Banerji,et al.  Heat Shock Protein 90 as a Drug Target: Some Like It Hot , 2009, Clinical Cancer Research.

[11]  K. Pienta,et al.  Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer , 2008, Journal of cellular biochemistry.

[12]  P. Ekman,et al.  Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  X. Long,et al.  Vimentin affects the mobility and invasiveness of prostate cancer cells , 2008, Cell biochemistry and function.

[14]  P. Albanese,et al.  Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin , 2008, PloS one.

[15]  P. S. Walmod,et al.  The Neural Cell Adhesion Molecule NCAM2/OCAM/RNCAM, a Close Relative to NCAM , 2008, Neurochemical Research.

[16]  Juan Pablo Albar,et al.  Advances in the analysis of protein phosphorylation. , 2008, Journal of proteome research.

[17]  S. Ofori-Acquah,et al.  Activated leukocyte cell adhesion molecule: a new paradox in cancer. , 2008, Translational research : the journal of laboratory and clinical medicine.

[18]  Yu-Tseung Liu,et al.  Quantitative proteomes and in vivo secretomes of progressive and regressive UV‐induced fibrosarcoma tumor cells: Mimicking tumor microenvironment using a dermis‐based cell‐trapped system linked to tissue chamber , 2007, Proteomics.

[19]  D. Tang,et al.  Cytosolic Accumulation of HSP60 during Apoptosis with or without Apparent Mitochondrial Release , 2007, Journal of Biological Chemistry.

[20]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[21]  Jens M. Rick,et al.  Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.

[22]  T. Ahlering,et al.  Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. , 2007, Archives of pathology & laboratory medicine.

[23]  S. Schmidt,et al.  Current methods for phosphoprotein isolation and enrichment. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  H. Miyake,et al.  Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. , 2007, The Journal of urology.

[25]  Richard S. Lee,et al.  Global methods for protein glycosylation analysis by mass spectrometry. , 2006, Biochimica et biophysica acta.

[26]  Yingming Zhao,et al.  A clean, more efficient method for in-solution digestion of protein mixtures without detergent or urea. , 2006, Journal of proteome research.

[27]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[28]  F. Ippoliti,et al.  IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis. , 2006, Anticancer research.

[29]  E. Jabs,et al.  A novel heterozygous deletion in the EVC2 gene causes Weyers acrofacial dysostosis , 2006, Human Genetics.

[30]  C. Cooper,et al.  Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer , 2004, British Journal of Cancer.

[31]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[32]  Kong-Joo Lee,et al.  Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. , 2004, Journal of biochemistry and molecular biology.

[33]  Xudong Yao,et al.  Trypsin catalyzed 16O-to-18O exchange for comparative proteomics: Tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers , 2003, Journal of the American Society for Mass Spectrometry.

[34]  Ruedi Aebersold,et al.  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.

[35]  S. Saika,et al.  Expression of Heat-shock Proteins and HSPmRNAÅ@in Corneal Epithelium Following an Exposure to Ethanol , 2003 .

[36]  Maria D Person,et al.  Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration , 2003, Oncogene.

[37]  L. Neckers,et al.  Heat shock protein 90 as a molecular target for cancer therapeutics. , 2003, Cancer cell.

[38]  M. Mann,et al.  Proteomic analysis of post-translational modifications , 2003, Nature Biotechnology.

[39]  E. Ginns,et al.  A new gene, EVC2, is mutated in Ellis-van Creveld syndrome. , 2002, Molecular genetics and metabolism.

[40]  I. N. Reid,et al.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma , 2002, The Prostate.

[41]  Salvatore Sechi,et al.  A method to identify and simultaneously determine the relative quantities of proteins isolated by gel electrophoresis. , 2002, Rapid communications in mass spectrometry : RCM.

[42]  R. Aebersold,et al.  Differential stable isotope labeling of peptides for quantitation and de novo sequence derivation. , 2001, Rapid communications in mass spectrometry : RCM.

[43]  M. Mann,et al.  Proteomics to study genes and genomes , 2000, Nature.

[44]  V. Castronovo,et al.  Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  J. Schalken,et al.  Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin. , 2000, Biochemical and biophysical research communications.

[46]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[47]  M. Webber,et al.  Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. , 1999, Cancer research.

[48]  A. Angelucci,et al.  Osteoblast conditioned media contain TGF‐β1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components , 1999, International journal of cancer.

[49]  M. Miller,et al.  Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. , 1998, Urology.

[50]  D. Grignon,et al.  Diagnostic and prognostic markers for human prostate cancer , 1997, The Prostate.

[51]  D. Tindall,et al.  The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease. , 1997, Endocrinology.

[52]  J. Lechner,et al.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.

[53]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[54]  Qiong Li,et al.  Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. , 2008, Anticancer research.

[55]  S. Nasim,et al.  Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas. , 2008, Oncology reports.

[56]  J. Kellermann.  ICPL--isotope-coded protein label. , 2008, Methods in molecular biology.

[57]  R. Tucker,et al.  Teneurins: transmembrane proteins with fundamental roles in development. , 2007, The international journal of biochemistry & cell biology.

[58]  A. Schmidt,et al.  A novel strategy for quantitative proteomics using isotope‐coded protein labels , 2005, Proteomics.

[59]  Jimmy R. Theriault,et al.  Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo , 2005, Cell stress & chaperones.

[60]  S. Arya,et al.  The LNCaP cell line--a new model for studies on human prostatic carcinoma. , 1980, Progress in clinical and biological research.